Michael Berger Evidence-based medicine debates
Amsterdam, Netherlands, 19-Sep-07

Kolterman, MD Orville G., United States Drugs for diabetes: are we getting value for money? Yes

Gale, Prof. Edwin, United Kingdom Drugs for diabetes: are we getting value for money? No

Holst, Prof. Jens J., Copenhagen, Denmark Will GLP-1-based therapies substitute sulfonylureas? Yes

Matthews, Prof. David R., United Kingdom Will GLP-1-based therapies substitute sulfonylureas? No